- Oral presentation
- Open Access
Characterization of specific HHV-6 and cell cycle genes implicated in virus-mediated G1/S cell-cycle arrest of glial precursors
© Mock et al; licensee BioMed Central Ltd. 2006
- Published: 21 December 2006
- Demyelinating Disease
- Human Herpesvirus
- Cell Cycle Gene
- Productive Infection
- Human Central Nervous System
Human herpesvirus 6 (HHV-6), a common resident virus of the human central nervous system (CNS), has been implicated in both acute and chronic inflammatory-demyelinating diseases. HHV-6 persists within the human CNS and has been described to infect mature oligodendrocytes and astrocytes. We recently demonstrated that HHV-6 infects human glial precursor cells, the ancestors of myelin producing oligodendrocytes, in vitro. Productive infection was demonstrated by both electron microscopy and expression of viral gene transcripts and proteins. Infection led to impairment of cell replication but not increased cell death. Infected cells showed decreased proliferation as measured by BrdU uptake and demonstrated strong G1/S-phase inhibition by FACS. We now present evidence detailing both specific viral and cell cycle genes inducing cellular G1/S cell cycle arrest. In parallel with human cells, the well characterized rodent oligodendroglial progenitor cell (OPC) system was used. Restricted infection of the murine cells was demonstrated by quantitative PCR, EM, and RT-PCR, and IFA for viral late proteins but, intriguingly, reproduced the G1/S arrest seen after productive virus infection of human progenitors. Restricted infection of murine OPCs was also found to be sufficient to induce the activation of DNA damage pathways previously reported by our group in human glial progenitors (ISNV 2004) and after productive infection in human lymphocytes (Oster et al. 2005). IFA and immunoblot again demonstrated expression of phospho-ATM, CHK-2, and p53 in infected murine precursors and two viral IE proteins were sufficient to induce G1/S arrest. Virus-induced cell-cycle arrest was accompanied by GalC+ differentiation with corresponding loss of the OPC pool as had been previously seen in the human precursors. Enhanced GFP-expressing murine OPCs have been created that can be readily infected with ALEXA-632-labeled HHV-6, allowing both sorting for infected cells and their identification in evaluating repair in demyelinated mice. In light of recent observations that repair of CNS remyelination is dependent on the generation of mature oligodendrocytes from the glial precursor cell pool, these findings may have broad implications for both the ineffective repair seen in human demyelinating diseases and the disruption of normal glial differentiation.
This article is published under license to BioMed Central Ltd.